UBX
$0.59
Unity Biotechnology
($.01)
(.97%)
UBX
Earnings Whisper ®
N/A
2nd Quarter June 2022
Consensus:  ($0.28)
Revenue:  $0.00 Mil
Tuesday
Aug 9
After the close
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when UBX reports earnings?
Beat
Meet
Miss

Where is UBX's stock price going from here?
Up
Flat
Down
Stock chart of UBX
Analysts
Summary of analysts' recommendations for UBX
Score
Grade
Pivots
Resistance
$0.66
$0.64
$0.62

$0.61

Support
$0.58
$0.57
$0.54
Tweet
Growth
Description
UNITY Biotechnology Inc. develops therapeutics which prevents, halts and reverses various diseases. The company's product portfolio includes UBX101, is designed to treat musculoskeletal disease with an initial focus on osteoarthritis. UNITY Biotechnology Inc. is based in California, United States.